ID   GALT3_HUMAN             Reviewed;         633 AA.
AC   Q14435; Q53TG9; Q7Z476;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 3;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 3;
DE            Short=GalNAc-T3;
DE            Short=pp-GaNTase 3;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 3;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3;
GN   Name=GALNT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Salivary gland;
RX   PubMed=8663203; DOI=10.1074/jbc.271.29.17006;
RA   Bennett E.P., Hassan H., Clausen H.;
RT   "cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-
RT   galactosamine polypeptide N-acetylgalactosaminyltransferase, GalNAc-
RT   T3.";
RL   J. Biol. Chem. 271:17006-17012(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=9295285; DOI=10.1074/jbc.272.38.23503;
RA   Wandall H.H., Hassan H., Mirgorodskaya E., Kristensen A.K.,
RA   Roepstorff P., Bennett E.P., Nielsen P.A., Hollingsworth M.A.,
RA   Burchell J., Taylor-Papadimitriou J., Clausen H.;
RT   "Substrate specificities of three members of the human UDP-N-acetyl-
RT   alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase
RT   family, GalNAc-T1, -T2, and -T3.";
RL   J. Biol. Chem. 272:23503-23514(1997).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9394011;
RA   Roettger S., White J., Wandall H.H., Olivo J.-C., Stark A.,
RA   Bennett E.P., Whitehouse C., Berger E.G., Clausen H., Nilsson T.;
RT   "Localization of three human polypeptide GalNAc-transferases in HeLa
RT   cells suggests initiation of O-linked glycosylation throughout the
RT   Golgi apparatus.";
RL   J. Cell Sci. 111:45-60(1998).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12708471; DOI=10.1111/j.1349-7006.2003.tb01348.x;
RA   Onitsuka K., Shibao K., Nakayama Y., Minagawa N., Hirata K., Izumi H.,
RA   Matsuo K., Nagata N., Kitazato K., Kohno K., Itoh H.;
RT   "Prognostic significance of UDP-N-acetyl-alpha-D-
RT   galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-
RT   T3) expression in patients with gastric carcinoma.";
RL   Cancer Sci. 94:32-36(2003).
RN   [8]
RP   INVOLVEMENT IN HFTC.
RX   PubMed=15133511; DOI=10.1038/ng1358;
RA   Topaz O., Shurman D.L., Bergman R., Indelman M., Ratajczak P.,
RA   Mizrachi M., Khamaysi Z., Behar D., Petronius D., Friedman V.,
RA   Zelikovic I., Raimer S., Metzker A., Richard G., Sprecher E.;
RT   "Mutations in GALNT3, encoding a protein involved in O-linked
RT   glycosylation, cause familial tumoral calcinosis.";
RL   Nat. Genet. 36:579-581(2004).
RN   [9]
RP   INVOLVEMENT IN HFTC.
RX   PubMed=15599692; DOI=10.1007/s00109-004-0610-8;
RA   Frishberg Y., Topaz O., Bergman R., Behar D., Fisher D., Gordon D.,
RA   Richard G., Sprecher E.;
RT   "Identification of a recurrent mutation in GALNT3 demonstrates that
RT   hyperostosis-hyperphosphatemia syndrome and familial tumoral
RT   calcinosis are allelic disorders.";
RL   J. Mol. Med. 83:33-38(2005).
RN   [10]
RP   FUNCTION.
RX   PubMed=16638743; DOI=10.1074/jbc.M602469200;
RA   Kato K., Jeanneau C., Tarp M.A., Benet-Pages A., Lorenz-Depiereux B.,
RA   Bennett E.P., Mandel U., Strom T.M., Clausen H.;
RT   "Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis.
RT   Secretion of fibroblast growth factor 23 requires O-glycosylation.";
RL   J. Biol. Chem. 281:18370-18377(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked
CC       oligosaccharide biosynthesis, the transfer of an N-acetyl-D-
CC       galactosamine residue to a serine or threonine residue on the
CC       protein receptor. Has activity toward HIV envelope glycoprotein
CC       gp120, EA2, Muc2 and Muc5. Probably glycosylates fibronectin in
CC       vivo. Glycosylates FGF23. Plays a central role in phosphate
CC       homeostasis. {ECO:0000269|PubMed:16638743,
CC       ECO:0000269|PubMed:9295285}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC       {ECO:0000269|PubMed:8663203}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-10232904, EBI-743771;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane
CC       {ECO:0000269|PubMed:9394011}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:9394011}. Note=Resides preferentially in the
CC       trans and medial parts of the Golgi stack.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14435-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14435-2; Sequence=VSP_011202, VSP_011203;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in organs that contain secretory
CC       epithelial glands. Highly expressed in pancreas, skin, kidney and
CC       testis. Weakly expressed in prostate, ovary, intestine and colon.
CC       Also expressed in placenta and lung and fetal lung and fetal
CC       kidney. {ECO:0000269|PubMed:12708471, ECO:0000269|PubMed:8663203}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- DISEASE: Tumoral calcinosis, hyperphosphatemic, familial (HFTC)
CC       [MIM:211900]: A severe metabolic disorder that manifests with
CC       hyperphosphatemia and massive calcium deposits in the skin and
CC       subcutaneous tissues. Some patients manifest recurrent, transient,
CC       painful swellings of the long bones associated with the
CC       radiographic findings of periosteal reaction and cortical
CC       hyperostosis and absence of skin involvement.
CC       {ECO:0000269|PubMed:15133511, ECO:0000269|PubMed:15599692}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Overexpressed in many differentiated carcinomas,
CC       suggesting that it may serve as a marker of tumor differentiation.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH56246.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 3;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_485";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X92689; CAA63371.1; -; mRNA.
DR   EMBL; AC009495; AAY14678.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11324.1; -; Genomic_DNA.
DR   EMBL; BC056246; AAH56246.1; ALT_INIT; mRNA.
DR   EMBL; BC113565; AAI13566.1; -; mRNA.
DR   EMBL; BC113567; AAI13568.1; -; mRNA.
DR   CCDS; CCDS2226.1; -. [Q14435-1]
DR   RefSeq; NP_004473.2; NM_004482.3. [Q14435-1]
DR   RefSeq; XP_005246506.1; XM_005246449.1. [Q14435-1]
DR   RefSeq; XP_011509231.1; XM_011510929.1. [Q14435-1]
DR   RefSeq; XP_016859259.1; XM_017003770.1. [Q14435-1]
DR   UniGene; Hs.170986; -.
DR   ProteinModelPortal; Q14435; -.
DR   SMR; Q14435; -.
DR   BioGrid; 108863; 3.
DR   IntAct; Q14435; 2.
DR   STRING; 9606.ENSP00000376465; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q14435; -.
DR   PhosphoSitePlus; Q14435; -.
DR   BioMuta; GALNT3; -.
DR   DMDM; 209572629; -.
DR   EPD; Q14435; -.
DR   MaxQB; Q14435; -.
DR   PaxDb; Q14435; -.
DR   PeptideAtlas; Q14435; -.
DR   PRIDE; Q14435; -.
DR   DNASU; 2591; -.
DR   Ensembl; ENST00000392701; ENSP00000376465; ENSG00000115339. [Q14435-1]
DR   GeneID; 2591; -.
DR   KEGG; hsa:2591; -.
DR   UCSC; uc010fph.2; human. [Q14435-1]
DR   CTD; 2591; -.
DR   DisGeNET; 2591; -.
DR   GeneCards; GALNT3; -.
DR   H-InvDB; HIX0024214; -.
DR   HGNC; HGNC:4125; GALNT3.
DR   HPA; HPA007613; -.
DR   MalaCards; GALNT3; -.
DR   MIM; 211900; phenotype.
DR   MIM; 601756; gene.
DR   neXtProt; NX_Q14435; -.
DR   OpenTargets; ENSG00000115339; -.
DR   Orphanet; 306661; Familial tumoral calcinosis.
DR   PharmGKB; PA28538; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   eggNOG; ENOG410XPMK; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOGENOM; HOG000038227; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q14435; -.
DR   KO; K00710; -.
DR   OMA; QYFEYSA; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q14435; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   Reactome; R-HSA-190372; FGFR3c ligand binding and activation.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; GALNT3; human.
DR   GeneWiki; GALNT3; -.
DR   GenomeRNAi; 2591; -.
DR   PRO; PR:Q14435; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115339; -.
DR   CleanEx; HS_GALNT3; -.
DR   ExpressionAtlas; Q14435; baseline and differential.
DR   Genevisible; Q14435; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IDA:BHF-UCL.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; IDA:BHF-UCL.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; IDA:UniProtKB.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Metal-binding; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    633       Polypeptide N-
FT                                acetylgalactosaminyltransferase 3.
FT                                /FTId=PRO_0000059106.
FT   TOPO_DOM      1     19       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     20     37       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     38    633       Lumenal. {ECO:0000255}.
FT   DOMAIN      504    630       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      184    293       Catalytic subdomain A.
FT   REGION      356    418       Catalytic subdomain B.
FT   METAL       277    277       Manganese. {ECO:0000250}.
FT   METAL       279    279       Manganese. {ECO:0000250}.
FT   METAL       415    415       Manganese. {ECO:0000250}.
FT   BINDING     225    225       Substrate. {ECO:0000250}.
FT   BINDING     254    254       Substrate. {ECO:0000250}.
FT   BINDING     387    387       Substrate. {ECO:0000250}.
FT   BINDING     418    418       Substrate. {ECO:0000250}.
FT   CARBOHYD    132    132       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    484    484       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    173    410       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    401    482       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    517    535       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    561    574       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    605    618       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   VAR_SEQ     173    192       CIEQKFKRCPPLPTTSVIIV -> YVEEYLLFILYHQALQG
FT                                REG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011202.
FT   VAR_SEQ     193    633       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011203.
FT   CONFLICT    481    481       Q -> R (in Ref. 1; CAA63371).
FT                                {ECO:0000305}.
SQ   SEQUENCE   633 AA;  72610 MW;  3019B2DCCC19A584 CRC64;
     MAHLKRLVKL HIKRHYHKKF WKLGAVIFFF IIVLVLMQRE VSVQYSKEES RMERNMKNKN
     KMLDLMLEAV NNIKDAMPKM QIGAPVRQNI DAGERPCLQG YYTAAELKPV LDRPPQDSNA
     PGASGKAFKT TNLSVEEQKE KERGEAKHCF NAFASDRISL HRDLGPDTRP PECIEQKFKR
     CPPLPTTSVI IVFHNEAWST LLRTVHSVLY SSPAILLKEI ILVDDASVDE YLHDKLDEYV
     KQFSIVKIVR QRERKGLITA RLLGATVATA ETLTFLDAHC ECFYGWLEPL LARIAENYTA
     VVSPDIASID LNTFEFNKPS PYGSNHNRGN FDWSLSFGWE SLPDHEKQRR KDETYPIKTP
     TFAGGLFSIS KEYFEYIGSY DEEMEIWGGE NIEMSFRVWQ CGGQLEIMPC SVVGHVFRSK
     SPHSFPKGTQ VIARNQVRLA EVWMDEYKEI FYRRNTDAAK IVKQKAFGDL SKRFEIKHRL
     QCKNFTWYLN NIYPEVYVPD LNPVISGYIK SVGQPLCLDV GENNQGGKPL IMYTCHGLGG
     NQYFEYSAQH EIRHNIQKEL CLHAAQGLVQ LKACTYKGHK TVVTGEQIWE IQKDQLLYNP
     FLKMCLSANG EHPSLVSCNP SDPLQKWILS QND
//
